Patent · US Active

Use of von Willebrand factor

US10478475B2 · kind B2 · utility

0Cited by
2References
12Claims
0Family size

Assignees

Inventors

Key dates

Filing dateApr 6, 2016
Grant dateNov 19, 2019
Priority date
Expiry dateApr 6, 2036

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K47/42
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to a von Willebrand factor composition for the prevention and/or the treatment of haemorrhage and/or bleeding in patients with mechanical circulatory support.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.